Clinical Trial

Early Aortic vaLve surgEry Versus wAtchful waitiNg Strategy in Severe Asymptomatic aOrtic reguRgitation

Study acronym: ELEANOR
Recruiting
View on ClinicalTrials.gov →
Summary
The optimal timing of surgical intervention in asymptomatic patients with severe aortic regurgitation remains controversial. As per cardiac magnetic resonance assessment, early surgical treatment will be compared with conventional guideline-based strategy in asymptomatic patients with severe aortic regurgitation.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-06-25; most recent amendment 2026-02-13.
Status change: Not Yet Recruiting → Recruiting 2023-03-22
Trial Details
NCT Number NCT05438862
Lead Sponsor Na Homolce Hospital
Collaborators: University Hospital Hradec Kralove, Centre of Cardiovascular and Transplantation Surgery, Czech Republic, St. Anne's University Hospital Brno, Czech Republic, VZW Cardiovascular Research Center Aalst, General University Hospital, Prague, University Clinical Centre of Republic of Srpska, AGEL Třinec-Podlesí Hospital
Conditions Aortic Valve Regurgitation
Enrollment 217 participants
Start Date 2022-09-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-17